SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-23-056026
Filing Date
2023-10-27
Accepted
2023-10-27 16:34:25
Documents
16
Period of Report
2023-08-23
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A pyxs-20230823.htm   iXBRL 8-K/A 55559
2 EX-23.1 pyxs-ex23_1.htm EX-23.1 4074
3 EX-99.1 pyxs-ex99_1.htm EX-99.1 1533381
4 EX-99.2 pyxs-ex99_2.htm EX-99.2 1300114
5 EX-99.3 pyxs-ex99_3.htm EX-99.3 855984
  Complete submission text file 0000950170-23-056026.txt   4054733

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20230823.xsd EX-101.SCH 2472
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20230823_pre.xml EX-101.PRE 10664
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20230823_lab.xml EX-101.LAB 14536
10 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20230823_htm.xml XML 5792
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40881 | Film No.: 231356005
SIC: 2834 Pharmaceutical Preparations